JPMorgan upgraded Afya (AFYA) to Overweight from Neutral with a price target of $24.50, up from $23.50. The company’s focus on medical education ?provides superior consistency and visibility,” the analyst tells investors in a research note. The firm says Afya is one of the most consistent players in the Brazilian education industry, with high visibility and never missing guidance. It views the stock as a “solid pick for the risk-averse.”
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AFYA: